Modeling the Impact of Time to Treatment on Syphilis Prevalence: A Theoretical Mathematical Model of People Living With HIV in Colombia
- PMID: 40265691
- PMCID: PMC12245600
- DOI: 10.1097/OLQ.0000000000002171
Modeling the Impact of Time to Treatment on Syphilis Prevalence: A Theoretical Mathematical Model of People Living With HIV in Colombia
Abstract
Background: Syphilis disproportionately affects people living with HIV (PLWH). Although screening is widely done for syphilis control, there are significant delays with time to treatment reaching 30 days in some settings in Colombia. Our study aimed to model the impact of reducing time to treatment on syphilis prevalence among PLWH in Colombia.
Methods: We developed a compartmental model to simulate syphilis transmission dynamics among PLWH, considering different stages of disease. The model included screening and treatment pathways and stratified the population into high (10%) and low (90%) sexual activity groups. Sensitivity analysis assessed the influence of various model parameters on the impact of reducing time to treatment.
Results: The model projected a syphilis prevalence of 7.7% in the base scenario, with increased prevalence in high versus low sexual activity groups (41.5% and 4.0%, respectively). Reducing the average time to treatment from 30 days to 1 day decreased the syphilis prevalence to 6.5%, or 7.1% when applied, respectively, to the entire population or only the high sexual activity group. Sensitivity analysis showed that reducing time to treatment to 1 day in 20% of the high activity group resulted in relative reductions ranging from -1.1% to -13.2% in syphilis prevalence, depending on parameter variations.
Conclusions: This study highlights the potential for reducing time to treatment to lower syphilis prevalence among PLWH. The findings emphasize the importance of targeted strategies in syphilis control efforts and underscore the complex interactions of model parameters influencing the impact of such interventions.
Copyright © 2025 American Sexually Transmitted Diseases Association. All rights reserved.
Conflict of interest statement
Conflict of Interest: JAGL has received support from Janssen, Carnott, Epidermique, Medivelius and Pharmaderm laboratories to attend dermatology meetings in Colombia, outside the scope of this work. JAGL has received also support from ISDIN laboratories to study an advanced diploma on skin exposoma at University of Barcelona and has received speaker fees from Jansenn to give a presentation on psoriasis outside the scope of this work. JDR has licensing agreements for recombinant Treponema pallidum proteins as syphilis serodiagnostic reagents with Biokit SA, Chembio, and Span Diagnostics. Other authors have no conflicts of interest to declare.
Similar articles
-
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001220. doi: 10.1002/14651858.CD001220.pub3. Cochrane Database Syst Rev. 2011. PMID: 21412869
-
School-based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents.Cochrane Database Syst Rev. 2016 Nov 8;11(11):CD006417. doi: 10.1002/14651858.CD006417.pub3. Cochrane Database Syst Rev. 2016. PMID: 27824221 Free PMC article.
-
Population-based interventions for reducing sexually transmitted infections, including HIV infection.Cochrane Database Syst Rev. 2004;(2):CD001220. doi: 10.1002/14651858.CD001220.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001220. doi: 10.1002/14651858.CD001220.pub3. PMID: 15106156 Updated.
-
Behavioral interventions for improving condom use for dual protection.Cochrane Database Syst Rev. 2013 Oct 26;2013(10):CD010662. doi: 10.1002/14651858.CD010662.pub2. Cochrane Database Syst Rev. 2013. PMID: 24163112 Free PMC article.
-
Antidepressants for depression in adults with HIV infection.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD008525. doi: 10.1002/14651858.CD008525.pub3. Cochrane Database Syst Rev. 2018. PMID: 29355886 Free PMC article.
References
-
- Pérez Clavijo CL. Gestational and congenital syphilis in Colombia, 2022 report. Instituto Nacional de Salud. Available from: https://www.ins.gov.co/buscador-eventos/Informesdeevento/SIFÍLIS GESTACI...
-
- Sabogal Apolinar AL. Gestational and congenital syphilis in Colombia, report until the epidemiological period XIII of 2016. Available from: https://www.ins.gov.co/buscador-eventos/Informesdeevento/S%C3%ADfilis%20...
-
- Cuenta de Alto Costo, Fondo Colombiano de Enfermedades de Alto Costo. HIV/AIDS state in Colombia 2020. BOGOTA D.C.; 2021. 141–142 p. Available from: https://cuentadealtocosto.org/site/wp-content/uploads/2021/05/CAC.Co_202...
-
- Cuenta de Alto Costo, Fondo Colombiano de Enfermedades de Alto Costo. HIV/AIDS state in Colombia 2022. Bogotá, D.C, Colombia; 2023.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical